Organization Will Offer Trump Account Contribution for Foster Children of Employees

WASHINGTON, June 16, 2026 — The Investment Company Institute (ICI) today announced an expansion of its corporate commitment to early-childhood savings. After ICI previously rolled out a $1,000 matching contribution for the Trump Accounts of children born to employees, it is now expanding on this effort to include a contribution to the accounts of children being fostered by ICI staff. The announcement follows First Lady Melania Trump’s work with the Treasury Department and state governors to ensure that foster children are enrolled in Trump accounts.

“Every child in America deserves a head start on their financial journey, and that includes the children in our nation’s foster care system,” said Eric J. Pan, ICI President and CEO. “We applaud the First Lady’s leadership in breaking down barriers so that foster children can benefit from compound growth and matching contributions. ICI is proud to establish a contribution for foster children under the care of ICI employees, so they too can move towards a secure financial future.”

For more details on ICI’s support for Trump Accounts, and our staff contribution initiatives, visit www.ici.org.

Contact: [email protected]

SOURCE Investment Company Institute

Funding round and NEDO Deep Tech Startup Support Program selection will support development and clinical adoption of DIOS‑101, an iPS cell‑derived co‑culture designed to reduce the burden of IVF treatment.

TOKYO, June 16, 2026 — Dioseve Inc. (“Dioseve”), a Tokyo-based fertility biotech company developing iPS cell-derived ovarian support technologies for in vitro oocyte maturation to reduce the physical and emotional burden of IVF, today announced the completion of an extended Series A round totaling over JPY 1.0 billion (around USD 7 million) via a third-party allotment of new shares. The financing brings the company’s cumulative equity funding to JPY 2.5 billion.

Archetype Ventures served as lead investor, with continued participation from DG Daiwa Ventures and Mirai Door (Asuka Innovation Fund). New investors D4V, Shionogi & Co., Ltd., and Pangaea Ventures also joined the round.

In addition, Dioseve has been selected for the 8th cohort of the NEDO Deep Tech Startup Support Program (DTSU), a Japanese government‑backed initiative that supports early-stage companies developing high‑risk, high‑impact technologies. When combined with this non-dilutive support, the company’s total funding to date reaches JPY 2.9 billion (around USD 20 million).

NEDO is Japan’s primary public research and development funding agency under METI, Ministry of Economy, Trade and Industry of Japan.

The funds raised in this round will be used primarily to advance the development and clinical translation of ReproNest, building out manufacturing and quality management infrastructure, and expanding regulatory and business development activities.

“IVF remains physically, emotionally, and financially demanding for many patients,” said Kazuma Kishida, CEO of Dioseve. “With this new funding and support from NEDO, we plan to accelerate the development of our iPS cell‑derived co‑culture technology, with the goal of making IVF treatment less burdensome and more accessible in everyday clinical practice.”

About ReproNest

Dioseve is a reproductive medicine company focused on the development of ReproNest, a co-culture product candidate that uses iPS cell-derived ovarian support cell-like cells to support oocyte maturation ex vivo. Unlike cell therapies, ReproNest is designed for use within the IVF process and is not administered directly to patients.

Conventional IVF protocols typically require around 10 days of hormonal stimulation, repeated clinic visits, self-administered injections, and substantial medication costs, all of which place significant physical and emotional demands on patients. ReproNest is intended to address these challenges by enabling minimal stimulation approaches combined with in vitro oocyte maturation (IVM), reducing the overall treatment burden.

Preclinical data to date suggest that ReproNest may improve oocyte maturation under experimental conditions compared with standard IVM culture systems. Dioseve is currently focused on validating its manufacturing processes, quality standards, and reproducibility ahead of clinical translation.

Looking ahead, the company sees additional applications in fertility preservation, including oocyte cryopreservation and pre-treatment fertility preservation for oncology patients. Ultimately, the company aims to contribute to extending women’s reproductive options by making in vitro oocyte maturation a more practical part of routine care.

Professor Katsuhiko Hayashi Joins as Scientific Advisor

Professor Katsuhiko Hayashi of the Osaka University Graduate School of Medicine has joined Dioseve as Scientific Advisor.

A globally recognized pioneer in reproductive biology, Professor Hayashi has published numerous landmark findings in germ cell research using iPS cells. He was named to Nature’s “Nature’s 10” in 2023 and TIME magazine’s “TIME100” in 2024. His involvement is expected to deepen Dioseve’s scientific foundation and accelerate progress toward new treatment options in assisted reproductive medicine.

About Dioseve Inc.

Dioseve Inc. is a Tokyo-based fertility biotech startup developing iPS cell-derived co-culture technologies aimed at improving outcomes in assisted reproduction. The company’s lead program, ReproNest, aims to improve in vitro oocyte maturation and reduce the burden associated with conventional IVF treatment.

Headquarters: Shin-Kiba, Koto-ku, Tokyo, Japan
CEO: Kazuma Kishida
Business Areas: Research, development, and manufacturing of assisted reproductive medicine products utilizing iPS cell differentiation technology
Website: https://dioseve.com/

The information contained in this release is current as of the date of publication.

SOURCE Dioseve Inc.

SCOTTSDALE, Ariz., June 16, 2026 — Jetstream Venture Fund (Jetstream), an innovative interval fund dedicated to opening access to institutional-grade deal flow for a wider mainstream audience, today announced it has established an investment interest in Rejuvenate Bio.

This strategic move allows Jetstream to secure early-stage positioning alongside top-of-industry heavyweights, including pharmaceutical giant Merck Animal Health, VCapital, and Digitalis. By locking in this deal, Jetstream delivers on its core mission: giving everyday retail investors a seat at venture capital’s most exclusive tables. The fund provides unique, high-upside opportunities normally restricted to institutional insiders or vetted private equity elites.

Groundbreaking Longevity Science

Spun out of the pioneering Harvard Medical School laboratory of Dr. George Church, Rejuvenate Bio is dedicated to shifting chronic disease treatment from reactive symptom management to cellular-level resolution. Utilizing a proprietary, non-genome-editing gene therapy platform, the biotechnology company develops groundbreaking, single-dose treatments that provide lifelong, systemic benefits.

Its current pipeline addresses high-prevalence chronic conditions including heart failure, metabolic disease, and age-related mutations. The company’s lead human program (RJB-0402) targets a life-threatening inherited heart condition, while its animal health divisions de-risk human development and generate near-term revenue through strategic commercial partnerships.

“Securing early-stage access to a category-defining startups that are backed by Merck’s capital and validation is a textbook example of how Jetstream unlocks deal flow that was traditionally reserved for institutional-grade investors,” said Doug Sylvester, Portfolio Manager at Jetstream.

Unlocking the Venture Ecosystem

While traditional venture capital firms lock out the public with million-dollar minimums and high carried interest fees, Jetstream offers an innovative regulatory pathway. As an interval fund, it features lower investment minimums, no carried interest, and structured transparency, including increasing daily Net Asset Value (NAV) reporting frequencies as its early-stage portfolio matures.

“Entering a disruptive biotechnology company during its Series A window offers exponentially higher return potential than waiting to buy post-IPO equities,” added James Mago, Portfolio Strategy lead at Jetstream. “We are proud to give individual investors direct, ground-floor access to the future of longevity science.”

About Jetstream Venture Fund

Jetstream Venture Fund is an interval fund managed by Xcellerant Ventures and Sweater Industries LLC, seeking to provide investors access to high-growth companies with lower minimums and no carried interest. To learn more or view current portfolio data, visit https://www.jvf.vc.

Schedule a Call with the Jetstream Investment Team Here

Media Contact: Dawson Fearnow, MMPR Marketing, [email protected]

SOURCE Jetstream Venture Fund

The funding accelerates Copia’s work to give industrial teams one platform to manage, back up, and recover the PLC code at the center of America’s industrial resurgence.

NEW YORK, June 16, 2026 — Copia Automation, a leader in industrial code management and resiliency, today announced $26 million in additional funding, bringing the company’s total raised to $55 million. AE Ventures and Squadra Ventures co-led the round, joined by KAS Venture Partners, with continued support from existing investors Construct Capital, Lux Capital, Ironspring Ventures, and Renegade Partners. The investment included a combination of equity financing and venture debt that the company will use to accelerate Copia’s mission to bring modern code management and recovery capabilities to the operational technology (OT) teams who are the first responders in the event of an industrial cyberattack or downtime incident.

Manufacturing is returning to the United States, critical infrastructure is being modernized and expanded, and new facilities are coming online. The industrial devices used to automate the physical world, like programmable logic controllers (PLCs), underpin the entire system. Yet the traditional IT software that protects everyday business systems cannot run on or safeguard these devices, because each PLC vendor relies on its own proprietary tooling, much as Windows software won’t run on macOS. The resilience of everything being built rests on how well that code is governed, versioned, and protected.

The stakes are rising in step with the threats. Attacks that exploit industrial devices have become a recurring headline, as adversaries increasingly take aim at the controllers running critical infrastructure. The teams responsible for automation devices are not equipped to manage automation device code because they do not have the essential tools for recovery their IT counterparts take for granted: validated backups, version control, and more recently, AI-powered coding tools.

Copia will use the funding to accelerate product development, support flexible deployments ranging from the cloud to customer-managed data centers and air-gapped environments, and back the teams on the front lines of OT incident response.

“The most critical code in the world has been managed with the least support, and that no longer holds in an economy being rebuilt on automation,” said Adam Gluck, founder and CEO of Copia Automation. “This is about the readiness and resilience of the infrastructure modern industry depends on, making sure that when something goes wrong, teams can recover quickly and maintain uptime. This funding lets us continue building the platform that makes that possible.”

“Copia has built the category-defining platform for industrial code management at exactly the moment the market needs it most,” said Tyler Rowe, Partner at AE Ventures, the venture capital platform of AE Industrial Partners, LP. “As manufacturers modernize legacy infrastructure, reshore production, and face a rapidly evolving cyber threat landscape, industrial code is becoming a strategic asset that must be governed with the same rigor as enterprise software. In sectors like aerospace, defense, energy, and critical infrastructure, traceability, security, and recovery are no longer optional. We’re excited to co-lead this financing and support Copia as it becomes the system of record for the world’s most critical industrial operations.”

“Cybersecurity has come a long way, but critical infrastructure remains one of the most vulnerable and under-addressed attack surfaces,” said Squadra Ventures Managing Partner Guy Filippelli. “It has never been more important to safeguard the industrial control systems that keep our society running, and Copia has the vision and execution tenacity to do it. Adam and team have demonstrated unmatched hustle and ability to innovate at the point where physical meets digital.”

Copia was founded on the idea that the code running the physical world deserves the same discipline and governance that software has leveraged for almost two decades. With this investment, the company will keep building toward a single platform industrial organizations can use to protect, govern, and evolve their most critical automation code.

About Copia Automation
Copia Automation provides visibility, traceability, and control across the full automation lifecycle, helping industrial teams maximize uptime, strengthen governance, and build resilient operations. From OT teams on the plant floor to the executives accountable for cyber resilience and compliance, Copia gives organizations a single platform to manage, secure, and recover the industrial code that runs the physical economy. Learn more at copia.io.

SOURCE Copia Automation

• Atom Computing has raised over $300 million to date, including a $100 million Series C round led by Third Point Ventures and a planned $100 million from the U.S. Department of Commerce, to speed development and deployment of fault-tolerant quantum computers.
• Following recent technical and commercial milestones, Atom Computing has emerged as a leader in the race to build utility-scale quantum computers.
• Recent funding will accelerate the development and delivery of commercial on-premises quantum systems, at scale, for enterprise and government customers worldwide.

BOULDER, Colo., June 16, 2026 — Atom Computing today announced it has raised a total funding of more than $300 million to accelerate the development and deployment of commercial-scale fault-tolerant quantum computers. The total includes a $100 million Series C investment round and a signed Letter of Intent with the U.S. Department of Commerce for $100 million. The Series C round was led by Third Point Ventures, with participation from DCVC, Cisco Investments, and others.

Atom Computing has emerged as a leader in the race to build practical quantum computers using neutral atoms. The company recently announced a full demonstration of quantum error correction on its quantum computers, making it only one of two companies in the quantum industry to have done so, and the first company to do this demonstration using neutral-atom technology.

The company continues to build momentum using its neutral-atom technology. In 2023, Atom became the first quantum company to surpass the 1,000-qubit threshold for a universal gate-based system. The company is currently performing in Stage B of the Defense Advanced Research Projects Agency (DARPA) Quantum Benchmarking Initiative (QBI) to explore paths to utility-scale quantum systems while also installing the world’s first commercial quantum computer with logical qubits in partnership with Microsoft. Atom Computing, named to Fast Company’s list of the World’s Most Innovative Companies, is also engaged in strategic collaborations with Cisco and NVIDIA.

“Quantum computing is entering a new phase where technical breakthroughs are translating into real-world systems and global adoption, fueled by our neutral-atom technology,” said Dr. Ben Bloom, CEO and Founder of Atom Computing. “We have strong momentum, and we are accelerating the development of utility-scale quantum computers and expanding access to our technology for customers solving some of the world’s most complex computational challenges.”

“Third Point Ventures has backed Atom Computing since their Series B, and leading this Series C reflects our deepening conviction in both the team and the technology,” said Curtis McKee, Partner at Third Point Ventures. “Neutral-atom quantum computing is one of the most credible paths to fault-tolerant systems at scale, and we believe commercial breakthroughs — in cybersecurity, defense, drug discovery, and financial modeling — are closer than the market appreciates. Atom Computing will be at the center of that moment.”

Atom Computing is using its recent funding for:

• Scaling next-generation quantum computers with higher qubit counts and improved fidelity
• Advancing the software, control systems, and error correction capabilities necessary for logical qubit operations
• Expanding global deployments, including on-premises systems for government, enterprise, and research customers
• Growing the company’s engineering, research, and go-to-market teams

“Atom Computing’s roadmap and execution towards a neutral atom fault tolerant quantum computing is truly impressive. DCVC has been with the Atom team from the start, and we are delighted to double down!” said Dr. Prineha Narang, a DCVC Operating Partner.

“Quantum computing is rapidly evolving from a research pursuit into a technology platform with real-world enterprise implications. As it matures, the industry will require scalable infrastructure, secure networking, and strong ecosystem collaboration to support real-world deployment,” added Aleem Rizvon, Vice President, Cisco Investment. “We are excited to invest in Atom Computing as it establishes itself as a leader in neutral-atom quantum computing.”

As industries increasingly explore quantum computing for applications in materials science, pharmaceuticals, energy, and logistics, demand is growing for systems capable of unlocking commercially relevant quantum applications. Atom Computing’s unique approach to quantum computing, utilizing arrays of optically-trapped neutral atoms, is widely recognized as one of the most viable paths to reaching commercial utility and positions the company to play a leading role in enabling practical quantum applications in the years ahead.

About Atom Computing
Atom Computing is developing large-scale quantum computers to enable companies and researchers to achieve unprecedented computational breakthroughs. Utilizing highly scalable arrays of optically trapped neutral atoms, the company has developed systems with over 1,200 qubits, featuring advanced capabilities towards fault-tolerant quantum computing. Atom Computing’s on-premises systems provide customers with new computational tools and logical qubit capabilities to address increasingly complex applications and to grow their quantum ecosystem. In 2025 Atom Computing sold its first commercial on-premises quantum computer to QuNorth, a Nordic quantum initiative funded by EIFO and Novo Nordisk Foundation. Learn more at atom-computing.com and follow us on LinkedIn.

SOURCE Atom Computing

State-of-the-art, in-house models power more than 3.5 million long, complex conversations each week across regulated industries

SAN FRANCISCO, June 16, 2026 — Bland today announced it has raised a $50 million Series C, underscoring its leadership position in voice AI for complex, real-world conversations. The round was led by Dell Technologies Capital, with participation from HubSpot Ventures, Archerman Capital, and Tribeca Venture Partners. All existing investors also participated, including Emergence Capital, Upfront Ventures, Scale Venture Partners, Y Combinator, Max Levchin, Piotr Dąbkowski, and Jeff Lawson.

In under three years since its founding, Bland has raised more than $100 million and is trusted by leading organizations including Samsara, Kin Insurance, and CNO Financial Group. The company’s rapid adoption reflects demand for AI systems that can handle the most complex, high-stakes interactions at scale.

While most of the market is built on top of third-party foundation models, Bland develops its own models in-house, purpose-built for voice. These systems are designed to take on long, unpredictable, high-stakes conversations that short calls, scripts, and phone trees cannot handle.

Today, Bland handles more than 3.5 million calls per week across healthcare, financial services, and other regulated industries where conversations are complex and mistakes carry real consequences.

“Most voice AI systems are built for simple interactions,” said Isaiah Granet, CEO and co-founder of Bland. “We are focused on the calls that are hardest to automate. The ones that are long, non-linear, and where things can go wrong at any point.”

AI Is Moving Into the Conversations That Actually Matter

A typical Bland call can last 30 to 45 minutes.

In healthcare, that can mean walking an elderly patient through using a blood pressure cuff, troubleshooting issues, interpreting readings, and determining whether to escalate to emergency services. The conversation shifts constantly and rarely follows a fixed path.

These are the interactions most systems cannot handle.

“They’re not linear,” said Granet. “They’re meandering. They require judgment. That’s where the real work is.”

While many voice platforms focus on transactional use cases such as ecommerce, scheduling, and basic support routing, Bland is designed to take ownership of the interaction itself.

From Scripts to Systems That Can Own the Call

Bland replaces rigid scripts with models that track context across long conversations, adapt in real time, and carry interactions from start to finish.

Because those models are built in-house, the company can optimize directly for the constraints of voice, including latency, interruption, ambiguity, and continuity. These are treated as core system requirements, not edge cases.

“Voice is its own domain,” said Granet. “If you want to handle these kinds of calls, you have to build specifically for it.”

This approach allows customers to move beyond incremental efficiency gains and rethink how work gets done. Instead of deflecting a small percentage of volume, organizations can automate entire categories of conversations that were previously handled by large teams.

New Investment Fuels Next Phase of Growth

With this new funding, Bland will expand its research efforts, grow its engineering team, and continue scaling its platform across industries where conversations are central to operations.

“Voice is one of the hardest problems in AI, and Bland is one of the few companies tackling it at the level required for real-world deployment,” said Elana Lian, Partner at Dell Technologies Capital. “Their decision to build models in-house and focus on complex, high-stakes interactions has positioned them ahead of the market.”

About Bland

Bland is a voice AI platform for deploying production-grade AI agents across phone, SMS, and chat, enabling companies to automate customer interactions and drive measurable business outcomes.

With 250+ enterprise customers, hundreds of thousands of self-service users, and over 175 million AI phone calls handled just last year, Bland powers complex, high-reliability conversations at scale. Visit https://bland.com/ to learn more.

SOURCE Bland

Building the physical world’s first agentic AI foundation model, already deployed with Blue Origin, Cadillac F1, and Sandvik, the company is bringing AI out of the digital world and onto the factory floor

TEL AVIV, Israel and NEW YORK, June 16, 2026 — Limitless Labs (formerly LimitlessCNC), the world’s first Agentic Physical AI platform for CAD/CAM (Computer-Aided Design and Computer-Aided Manufacturing) in mechanical manufacturing, today announced a $20 million Series A round co-led by Dell Technologies Capital and Square Peg, with participation from Grove Ventures, Meron Capital, and Kinetica. The agent works inside the CAD/CAM systems that engineers already use, helping manufacturers capture, standardize, and scale the expertise of their most experienced programmers.

Since emerging from stealth, Limitless Labs has scaled from initial pilots to full production deployments with Blue Origin, Cadillac F1, Sandvik, and Iscar across aerospace, defense, motorsports, and industrial machinery, reducing CNC programming time by up to 50%. The platform is ITAR-compliant and deployable on AWS GovCloud, meeting the rigorous security requirements of the industry’s most regulated environments.

As demand for complex, high-precision parts grows, manufacturers are facing a deepening talent crisis. Nearly a quarter of the US manufacturing workforce is 55 or older, and 97% of manufacturers cite knowledge retention as their top concern. With 409,000 positions already unfilled, a gap projected to reach 1.9 million by 2033, programming critical aerospace, defense, medical, and industrial parts still depends on manual work, tribal knowledge, and years of hard-won experience.

“The manufacturing world doesn’t just need more automation, it needs a better way to capture and scale the expertise that still lives inside the heads of a relatively small number of experienced machinists,” said David Priev, Co-founder and CEO of Limitless Labs. “We built Limitless Labs to work inside the CAD/CAM systems manufacturers already use, helping teams standardize best practices, reduce programming bottlenecks, and free senior programmers to focus on the hardest work, without giving up control. We believe the next major AI platform will be built for the physical world, and that starts with giving manufacturers a way to scale their best knowledge across every new part and every new engineer.”

At the core of the platform is the company’s Physical AI Foundation Model, trained not on text or generic code, but on the physics of metal cutting, CAD geometry, and the operational constraints of real machines. The model powers Limitless Labs’ CAM Agent, which currently works inside platforms such as Mastercam, NX, and Creo. Given a CAD file, the CAM Agent identifies features, recommends tools, sequences operations, generates toolpaths, and helps produce a shop-floor-ready program, reducing programming time by up to 50% while engineers maintain control of the workflow.

“Limitless Labs represents the next wave of enterprise AI, moving beyond digital workflows and into the physical world of precision manufacturing,” said Yair Snir, Managing Director at Dell Technologies Capital. “Their unique foundation model and the caliber of their production deployments gave us conviction that this team is building the defining platform for AI in manufacturing.”

“Eighteen months ago, we backed Limitless Labs’ vision that agentic AI could transform the factory floor,” said Lior Handelsman, General Partner at Grove Ventures and Co-Founder of SolarEdge. “What the team has achieved since then has exceeded expectations. They are combining deep technical innovation with practical software in a way that could reshape how the world’s most critical parts are made.”

The new funding will be used to build out a dedicated U.S. commercial organization, advance its Physical AI Foundation Model toward closed-loop CNC automation, and grow its CAM Agent, which helps manufacturers automate key parts of CNC programming inside the CAD/CAM systems engineers already use. The company plans to expand its deep-tech research lab in Tel Aviv and expects to roughly double headcount over the next 12 months. Limitless Labs will also be in attendance at Reindustrialize 2026 on June 16-17 in Detroit, Michigan, taking part in the push to rebuild American manufacturing, which continues to gain momentum.

About Limitless Labs

Limitless Labs, formerly LimitlessCNC, is the developer of the world’s first Agentic Physical AI platform for CAD/CAM in mechanical parts manufacturing. Its Physical AI Foundation Model powers an Agent that helps automate CNC programming inside the CAM systems engineers already use, including Siemens NX CAM, Mastercam, and PTC Creo. The platform is deployed across cloud, private VPC, and AWS GovCloud environments with full ITAR compliance support. Founded in 2024 by David Priev, Assaf Peleg, and Shahaf Finder, the company is headquartered in Tel Aviv and is expanding its commercial presence in the United States. The company has raised $27.3 million to date from Dell Technologies Capital, Square Peg, Grove Ventures, Meron Capital, and Kinetica. For more information, visit www.limitless-labs.ai.

Media Contact
Shahni Ben-Haim
SBH Media Relations
[email protected] 

SOURCE Limitless Labs

NASHVILLE, Tenn., June 16, 2026 — Eileen Inc., a next-generation retail technology platform, today announced a strategic investment from DisPact Ventures, a venture capital firm that backs disruptive brands and technologies across the consumer landscape, extending the company’s previously announced pre-seed round. The investment comes just months after Eileen’s $1 million pre-seed led by Top Shelf Ventures and will accelerate the expansion of its retail insights and execution platform, which bridges the gap between real-time store insights and operational execution for Bev Alc and CPG brands of all sizes.

Eileen’s core innovation is its Performance Hub, a centralized platform that integrates store-level data captured by its own network of “Shoppers,” paired with AI-driven analytics to act on that data on-the-ground at scale.

Since launching in January, Eileen has scaled quickly. The platform now serves over 70 brands across 49 states, supported by a network of 25,000+ Shoppers who have captured insights from over 90 retail banners and 5,600 unique stores. The rapid adoption underscores growing demand from consumer brands for faster, more affordable visibility into retail execution and in-store performance.

“Brands lose at the shelf because they can’t see the shelf,” said Jordan Karcher, Founder and CEO of Eileen Inc. “Our pre-seed proved there’s real demand for changing that. DisPact has built consumer brands that live or die at retail, and their partnership lets us expand the quality and availability of real-time, photo-verified shelf data to the brands that need it most, at a price they can actually afford.”

The company plans to use the new capital to:

• Scale the AI infrastructure
• Expand technical talent
• Accelerate go-to-market strategy

“Retail execution remains one of the largest blind spots in consumer products. Brands invest millions driving demand, only to lose sales because products aren’t on the shelf, displays aren’t built, or inventory issues go unnoticed. Eileen is solving that problem with a scalable, technology-driven approach that delivers real-time visibility and actionable intelligence at a fraction of the cost of traditional solutions. As operators and investors in consumer brands, we’ve experienced these challenges firsthand, and we’re excited to partner with Jordan and his team as they build what we believe can become the category-defining platform for retail execution and in-store intelligence.” said Andrew Merinoff, Founder and Managing Partner of DisPact Ventures.

About Eileen Inc.

Eileen Inc. provides a high-performance retail execution engine designed for the modern brand. By combining AI-driven analytics with a seamless Performance Hub, Eileen helps brands instantly bridge the gap between store-floor insights and operational execution.

About DisPact Ventures

DisPact Ventures is a venture capital firm founded by entrepreneur and investor Andrew Merinoff that partners with next-generation founders across consumer products, hospitality, technology, and retail. DisPact combines strategic capital with hands-on operating expertise, helping founders accelerate growth through access to industry relationships, distribution networks, retail partnerships, and experienced operators. Portfolio companies include SevenRooms, The Finnish Long Drink, Chinola Fresh Fruit Liqueurs, Coconut Cartel, SipMargs, Empirical Spirits, and other emerging consumer and technology businesses operating around the world.

Media Contact:

Jordan Karcher
[email protected]

SOURCE Eileen Inc.

MIAMI, June 16, 2026 — LEBEC, a global innovative finance platform, today announced a strategic investment from CCM Holding Company, LLC, the parent company to Community Capital Management, LLC (CCM). CCM is a $7 billion institutional asset manager with over 25 years of experience seeking to deliver competitive risk-adjusted market-rate returns alongside impact solutions. The investment marks a significant milestone as LEBEC scales its three integrated pillars: strategic advisory, investment management (LEBEC Capital Partners), and narrative change. LEBEC’s unique approach directs more capital toward leading innovations addressing systemic risks in sectors such as water, regenerative agriculture, energy, health, and infrastructure.

Founded in 1998, CCM develops market-rate strategies for institutional clients seeking strong financial performance and tangible societal outcomes. Its investment in LEBEC extends that legacy into private markets innovation. By combining CCM’s institutional scale and track record with LEBEC’s deep expertise in asset management, innovative finance, and social entrepreneurship, the partnership bridges the critical gap between traditional investing and the frontline solutions building a resilient global economy. It sets a powerful precedent for how the financial industry can unite to close the global $5 trillion annual financing gap for solutions addressing systemic risks.

“We are truly honored to welcome CCM as a partner,” said Alix Lebec, Founder and CEO of LEBEC. “The world’s most pressing challenges cannot be solved in silos. This investment validates our approach to mainstreaming innovative finance—by building diversified private market portfolios across interconnected sectors and driving narrative change across media and entertainment. Advancing human dignity and global resilience is essential for our planet and economy. To succeed, the financial innovations driving this work must be made understandable and culturally visible to all audiences through media and entertainment. Alyssa Greenspan and the entire CCM team share our vision for moving capital differently, and their trust in our team will accelerate our impact.”

“CCM is making a strategic investment in LEBEC based on our belief in Alix and her team’s vision and execution,” said Alyssa Greenspan, CFA, CEO and President of CCM. “The team brings clear purpose, deep experience, and a fresh approach to directing capital to businesses and projects with meaningful impact. We are excited to support LEBEC’s growth and encourage other investors and partners to engage with the work they are leading.”

This announcement follows the recent launch of LEBEC Capital Partners, which will construct and invest in diversified, multi-asset class portfolios of specialized private market funds. These portfolios accelerate decarbonization, adaptation, and economic mobility solutions while targeting attractive risk-adjusted returns. LEBEC Capital Partners is uniquely positioned to address emerging investment blind spots—most notably the physical infrastructure, water, and energy dependencies associated with scaling technologies like AI.

“Scaling innovations across critical resources like water, food, and clean energy must accelerate exponentially this decade,” said Julia Wilkinson, Managing Partner and Chief Investment Officer at LEBEC. “Despite this urgency, traditional markets consistently overlook the private market funds driving these solutions. LEBEC Capital Partners fills this gap. The portfolios of private market funds we invest in are scaling frontline solutions, and the data is clear: investing in decarbonization and adaptation could unlock an estimated $1.4 trillion in broader economic benefits—proving that systemic solutions are a fundamental driver of long-term value creation.”

About LEBEC
LEBEC is a global innovative finance platform addressing a $5T annual financing gap for systemic solutions building a resilient economy and planet. With 20+ years of experience across asset management, philanthropy, and social entrepreneurship, LEBEC is mainstreaming innovative finance through three integrated pillars: (a) strategic advisory, (b) investment management, and (c) narrative change.

LEBEC advises asset owners and social entrepreneurs on innovative finance strategies, narratives, and financial structuring. Through its investment manager, LEBEC Capital Partners, it constructs diversified private market fund portfolios designed to pursue competitive, risk-adjusted returns and accelerate decarbonization, adaptation, and economic mobility solutions. The LEBEC team brings deep cross-sector experience and emphasizes disciplined portfolio construction, thoughtful risk management, and long-term value creation.

For more information, visit lebec.co.

About Community Capital Management (CCM), LLC
Founded in 1998, Community Capital Management, LLC (CCM) is an investment adviser registered with the Securities and Exchange Commission. The firm’s mission seeks to deliver competitive risk-adjusted returns through investment strategies that contribute to positive societal outcomes. For more information, please visit: www.ccminvests.com.

Media Contacts
LEBEC
Surabhi Virnave
[email protected]
312-291-1099

Community Capital Management
Jamie Horwitz
[email protected]
954-298-6214

SOURCE LEBEC